3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Motor Activity
197
Breast Neoplasms
112
Neoplasms
83
Fatigue
29
Prostatic Neoplasms
27
Lung Neoplasms
20
Colorectal Neoplasms
20
Obesity
19
Polycystic Ovary Syndrome
14
Ovarian Neoplasms
11
Colonic Neoplasms
11
Carcinoma, Non-Small-Cell Lung
11
Rectal Neoplasms
10
Pancreatic Neoplasms
10
Lymphedema
10
Multiple Myeloma
9
Lymphoma
9
Hematologic Neoplasms
9
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Head and Neck Neoplasms
8
Weight Loss
7
Stomach Neoplasms
7
Cardiotoxicity
7
Peripheral Nervous System Diseases
6
Leukemia
6
Insulin Resistance
6
Esophageal Neoplasms
6
Brain Neoplasms
6
Sarcopenia
5
Endometrial Neoplasms
5
Interventions
Adalimumab
2
Vitamin D
1
Syringes
1
Sodium Chloride
1
Lysine Acetyltransferase 5
1
Injections
1
Holistic Health
1
High-Intensity Interval Training
1
Fish Oils
1
Fatty Acids, Omega-3
1
Exercise
1
Eicosapentaenoic Acid
1
Docosahexaenoic Acids
1
Cholecalciferol
1
Calcitriol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Arthritis, Rheumatoid
×
Exercise
×
Clear all
NCT05215509
2024-02-02
RABEX
Rigshospitalet, Denmark
Phase NA
Completed
69 enrolled